Episode Details

Back to Episodes
Smart Contact Lenses for IOP Monitoring: August 2026 Clinical Utility Results

Smart Contact Lenses for IOP Monitoring: August 2026 Clinical Utility Results

Published 2 months, 4 weeks ago
Description

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/smart-contact-lenses-for-iop-monitoring-august-2026-clinical-utility-results

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

Smart Contact Lenses for Intraocular Pressure Monitoring: August 2026 Clinical Utility Results Evidence reviewed through August 18, 2026. Introduction Smart contact lenses and other wearable sensors aim to solve a major problem in glaucoma care: eye pressure is measured only occasionally in most clinics, even though it changes throughout the day and may rise during sleep or while lying down. The August 2026 evidence is promising but more limited than some headlines suggest. The newest soft contact lens studies show that overnight and closed-eye monitoring is technically feasible. However, there is still no large, peer-reviewed clinical trial showing that an external smart contact lens improves vision, slows glaucoma progression, or reliably changes treatment based on automated alerts. The strongest real-world evidence for remote treatment decisions comes from implantable telemetric sensors and, to a lesser degree, home rebound tonometry rather than from external smart contact lenses. Nocturnal soft contact lens study Ongoing smart contact lens trial Implantable sensor progression study Executive Summary New soft contact lens technology: The 2026 nocturnal sensor demonstrated closed-eye and recumbent monitoring in a very small human pilot involving a healthy participant and a participant with pigmentary glaucoma. It reported encouraging comfort and signal stability, but no cohort-level adherence, data-completeness, treatment-change, or vision-outcome results. Advanced Materials report Triggerfish: The commercially available SENSIMED Triggerfish detects changes in ocular dimensions related to pressure, rather than directly reporting pressure in millimeters of mercury. It can identify the likely timing of pressure peaks, but its United States authorization limits clinical use to helping identify when conventional pressure measurement should be performed. United States Food and Drug Administration United States Food and Drug Administration review Implantable EyeMate sensors: These devices provide the most mature continuous telemetric data. In one remote-monitoring study, data led to treatment changes in 5 of 34 patients who submitted measurements, while treatment changes were considered in another 5 patients. Remote telemetric monitoring study Home tonometry: iCare HOME2 offers a more practical alternative for intermittent home measurements. In a 75-patient prospective cohort, 65% obtained at least six measurements per day, while 19% obtained fewer than two per day. The device identified maximum pressure outside clinic hours in 36% of patients. Home tonometry cohort Payer position: Publicly available 2026 policies from Aetna and Anthem classify continuous pressure monitoring and home tonometry as investigational, unproven, or not medically necessary for routine glaucoma care. Aetna policy Anthem policy What the Devices Actually Measure External smart contact lenses There are two broad approaches: Relative-signal sensors, such as Triggerfish, detect changes in corneal or corneoscleral shape that are believed to reflect pressure changes. Quantitative sensors, such as the newer Purdue-developed soft lenses, attempt to convert mechanical deformation into an absolute pressure estimate in millimeters of mercury. This distinction is clinically important. A relative signal may show that a patient’s pressure-relate

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us